IDO is highly expressed in the tumor microenvironment (TME), the introduction of CY1-4 into the nano-skeleton delivery system dramatically increased the IDO inhibition ability, and greatly reduced the Kyn/Trp ratio. This evidence concerns the gene IDO1 and neoplasm.